ChiCTR-TRC-13002977
正在进行
/
/
/
2013-01-06
/
/
Dementia
Acupressure for agitation in dementia
The effect of acupressure in managing agitation on nursing home resident with dementia
Aims to assess the effect and safety of Acupressure, applying manual pressure on subject's acupoints on the body; Duration of intervention: Tentatively 4 weeks (will be revised after testing for the ideal duration in the pilot study); Description / name of comparative treatments: Comparison group 1: Sham-acupressure, applying manual pressure on the subject's body without acupoints or acupoints without therapeutic effects in theory. Comparison 2: Usual care, the care provided by the nursing home that it will not be manipulated by the research team.
随机平行对照
Ⅰ期
randomized placebo control
/
Nil
/
99
/
2014-02-01
1990-01-01
/
1) Older people (over 65 years old); 2) Diagnosed and documented to have dementia by a physician (according to DSM-IV-TR); 3) In a state of agitation (according to the criteria set in the instruction manual of Cohen-Mansfield Agitation Inventory).；
请登录查看1) Skin problems on acupoints (eg. skin breakdown, infection); 2) Musculo-skeletal problems (eg. amputation on the acupoints).；
请登录查看School of Nursing, The Hong Kong Polytechnic University
/
School of Nursing, The Hong Kong Polytechnic University的其他临床试验
School of Nursing, The Hong Kong Polytechnic University的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04